0001933805-22-000001.txt : 20220614 0001933805-22-000001.hdr.sgml : 20220614 20220613213750 ACCESSION NUMBER: 0001933805-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220614 DATE AS OF CHANGE: 20220613 EFFECTIVENESS DATE: 20220614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lattice Therapeutics, Inc. CENTRAL INDEX KEY: 0001933805 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-449072 FILM NUMBER: 221013308 BUSINESS ADDRESS: STREET 1: 4314 13TH PLACE NE CITY: WASHINGTON STATE: DC ZIP: 20017 BUSINESS PHONE: 205-837-8664 MAIL ADDRESS: STREET 1: 4314 13TH PLACE NE CITY: WASHINGTON STATE: DC ZIP: 20017 D 1 primary_doc.xml X0708 D LIVE 0001933805 Lattice Therapeutics, Inc. 4314 13TH PLACE NE WASHINGTON DC DISTRICT OF COLUMBIA 20017 205-837-8664 DELAWARE Hatcht LLC None Corporation true 2020 Patrick Michael McTamney c/o Lattice Therapeutics, Inc. 4313 13th Place NE Washington DC DISTRICT OF COLUMBIA 20017 Executive Officer Director Jack Guy DaSilva c/o Lattice Therapeutics, Inc. 4314 13th Place NE Washington DC DISTRICT OF COLUMBIA 20017 Director Biotechnology Decline to Disclose 06b false 2022-05-26 false true false 0 900000 300000 600000 false 3 0 0 0 false Lattice Therapeutics, Inc. /s/ Patrick Michael McTamney Patrick Michael McTamney Chief Executive Officer 2022-06-13